Esperion discovers, develops, and commercializes innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why Esperion’s team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; Esperion provides the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is Esperion’s life’s work.